Stocks:
5,168
ETFs:
2,288
Exchanges:
11
Market Cap:
$63.92T
24h Vol:
$4.36B
Dominance:
MSFT:4.92%
Stocklytics Platform
Instrument logo  INDV
Indivior PLC - Ordinary Shares
INDV
53 / 100
$19.47arrow_drop_down4.27%-$0.87

Performance History

Stocklytics logo
Key Stats
Open$19.58
Prev. Close$20.34
EPS0.01
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$2.76B
PE Ratio1,947.00
LOWHIGH
Day Range19.17
19.69
52 Week Range14.38
26.50
Ratios
P/B Ratio47.44
Revenue$1.09B
Operating M. %19.80%
Earnings$2.00M
Earnings Growth %103.77%
EBITDA Margin %24.61%
ROE %7.84%
EPS0.01

Score Breakdown

53vs 55. Market Avg.

All Score 53 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

INDVMARKET
Value2040
Quality4240
Ownership4117
Growth6245
Dividends-37
check_circle

Indivior PLC - Ordinary Shares's Price growth average in the last 3 years of 148.64% is great compared to market average of 7.17%. This indicates INDV could be a good value stock.

Financial Forecast

AI Price Prediction

line chart placeholder

Analyst Ratings

info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Correlated Companies

PRICE$751.11
24H (%)arrow_drop_down1.11%
24H ($)-$8.48
MARKET CAP$724.46B
PRICE$437.56
24H (%)arrow_drop_down0.94%
24H ($)-$4.16
MARKET CAP$414.91B
PRICE$147.58
24H (%)arrow_drop_down0.81%
24H ($)-$1.20
MARKET CAP$361.94B
PRICE$126.33
24H (%)arrow_drop_up0.14%
24H ($)$0.18
MARKET CAP$321.01B

About Indivior PLC - Ordinary Shares (INDV)

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders. The company's product pipeline focuses on treating opioid use disorder, addiction, and schizophrenia. It markets and promotes SUBLOCADE injection for subcutaneous use; and SUBOXONE sublingual film, SUBOXONE sublingual tablet, and SUBUTEX sublingual tablet. The company operates in approximately 40 countries worldwide. It has collaboration agreement with Addex Therapeutics Ltd. The company was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.

Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
CEO
Mr. Mark Crossley
Headquarters
North Chesterfield
Employees
1000
Exchange
NASDAQ
add Indivior PLC - Ordinary Shares to watchlist

Keep an eye on Indivior PLC - Ordinary Shares

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help
What is Indivior PLC - Ordinary Shares's (INDV) price per share?

The current price per share for Indivior PLC - Ordinary Shares (INDV) is $19.47. The stock has seen a price change of -$0.87 recently, indicating a -4.28% change. This reflects the stock's recent market performance and investor sentiment.

help
What is the 52-week high and low for Indivior PLC - Ordinary Shares (INDV)?

For Indivior PLC - Ordinary Shares (INDV), the 52-week high is $26.5, which is 36.11% from the current price. The 52-week low is $14.38, the current price is 35.39% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help
Is Indivior PLC - Ordinary Shares (INDV) a growth stock?

Indivior PLC - Ordinary Shares (INDV) has shown an average price growth of 148.64% over the past three years. It has received a score of 96 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Indivior PLC - Ordinary Shares as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help
What is Indivior PLC - Ordinary Shares (INDV) stock price performance year to date (YTD)?

As of the latest data, Indivior PLC - Ordinary Shares (INDV) has a year-to-date price change of 25.86%. Over the past month, the stock has experienced a price change of -8.16%. Over the last three months, the change has been 22.68%. Over the past six months, the figure is -4.09%.

help
Is Indivior PLC - Ordinary Shares (INDV) a profitable company?

Indivior PLC - Ordinary Shares (INDV) has a net income of $2M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 82.98% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 19.8% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $1.09B, with a revenue growth rate of 21.31%, providing insight into the company's sales performance and growth. The gross profit is $907M. Operating income is noted at -$8M. Furthermore, the EBITDA is $62M.

help
What is the market capitalization of Indivior PLC - Ordinary Shares (INDV)?

Indivior PLC - Ordinary Shares (INDV) has a market capitalization of $2.77B. The average daily trading volume is 117.09K, indicating the stock's liquidity and investor engagement.

News

email

Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Approach investments with caution like a driver who slows down on a curvy road.